Literature DB >> 1576407

Small antibiotic resistance plasmids in Staphylococcus intermedius.

R T Greene1, S Schwarz.   

Abstract

Antibiograms and plasmid profiles were evaluated for 116 Staphylococcus intermedius isolates collected from dogs in Germany and in the USA. Of the 26 S. intermedius isolates from Germany, 9 (34.6%) carried plasmids, while 20 (22.2%) of the 90 S. intermedius isolates from the USA were found to be plasmid-positive. Eight small resistance plasmids were identified and characterized using protoplast transformations and restriction endonuclease analyses. Five plasmids (3.8 and 3.9 kb) encoded for chloramphenicol resistance, 2 plasmids (each 2.5 kb) carried determinants for macrolide-lincosamide resistance, and one plasmid (4.5 kb) conferred resistance to tetracycline. Detailed restriction maps of these plasmids were constructed and served for structural comparisons with other small resistance plasmids found in staphylococci. These comparisons implied marked structural homologies with those prototype plasmids initially characterized in S. aureus of human origin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576407     DOI: 10.1016/s0934-8840(11)80545-1

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  3 in total

1.  Antimicrobial susceptibility and rRNA gene restriction patterns among Staphylococcus intermedius from healthy dogs and from dogs suffering from pyoderma or otitis externa.

Authors:  K Pedersen; H C Wegener
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

2.  The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis.

Authors:  H Kruse; M Hofshagen; S I Thoresen; W P Bredal; I Vollset; N E Søli
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

3.  Catheter-related bacteremia associated with coagulase-positive Staphylococcus intermedius.

Authors:  F Vandenesch; M Célard; D Arpin; M Bes; T Greenland; J Etienne
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.